Anxiety and fatty liver disease are increasingly recognised as interconnected health concerns affecting many people in the UK. Non-alcoholic fatty liver disease (NAFLD) affects up to one in three adults, whilst anxiety disorders represent one of the most common mental health conditions. Although anxiety does not directly cause fatty liver disease, emerging research suggests these conditions may influence one another through shared metabolic, behavioural, and inflammatory pathways. Understanding this relationship enables a holistic approach to care, addressing both liver health and psychological wellbeing. This article explores the connections between anxiety and fatty liver, their impact on one another, and practical strategies for managing both conditions effectively.
Summary: Anxiety and fatty liver disease do not have a direct causal relationship, but they may influence one another through shared metabolic, behavioural, and inflammatory pathways.
- Non-alcoholic fatty liver disease (NAFLD) affects up to one in three UK adults and shares risk factors with anxiety including poor diet, physical inactivity, and disrupted sleep.
- Chronic anxiety may contribute to insulin resistance and central adiposity through elevated cortisol, both of which are risk factors for hepatic steatosis.
- Patients with NAFLD report higher rates of anxiety symptoms, potentially due to health-related worry, lifestyle modification demands, and systemic inflammation.
- Cognitive behavioural therapy (CBT) is the first-line psychological intervention for anxiety disorders as recommended by NICE guidance.
- SSRIs such as sertraline require careful dosing in hepatic impairment, and benzodiazepines should be avoided due to dependence risks and potential for hepatic encephalopathy.
- Regular physical activity, Mediterranean-style diet, and gradual weight loss of 7–10% body weight benefit both liver health and anxiety symptoms.
Table of Contents
- Understanding the Link Between Anxiety and Fatty Liver Disease
- How Fatty Liver Disease Can Affect Mental Health and Anxiety
- Managing Anxiety When You Have Fatty Liver Disease
- Lifestyle Changes to Support Both Liver Health and Mental Wellbeing
- When to Seek Medical Help for Anxiety and Fatty Liver Concerns
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Understanding the Link Between Anxiety and Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) affects up to one in three adults in the UK and represents a spectrum of liver conditions characterised by excessive fat accumulation in hepatocytes. Whilst the primary risk factors include obesity, type 2 diabetes, and metabolic syndrome, emerging research suggests associations between NAFLD and mental health conditions, particularly anxiety disorders. (Note: International nomenclature is evolving toward metabolic dysfunction-associated steatotic liver disease [MASLD], though NAFLD remains widely used in UK clinical practice.)
The connection between anxiety and fatty liver disease is complex and multifactorial. Chronic psychological stress and anxiety may influence liver health through several mechanisms, though causality has not been definitively established. Elevated cortisol levels associated with persistent anxiety have been linked to insulin resistance and central adiposity, both key contributors to hepatic steatosis. Additionally, anxiety often correlates with behaviours that increase NAFLD risk, including poor dietary choices, physical inactivity, disrupted sleep patterns, and increased alcohol consumption as a coping mechanism. It is important to stay within UK low-risk drinking guidelines (no more than 14 units per week spread over three or more days) and ideally to avoid alcohol entirely if you have fatty liver disease.
Conversely, individuals diagnosed with fatty liver disease may experience heightened anxiety related to their diagnosis, concerns about disease progression, and lifestyle modification requirements. Studies have demonstrated that patients with NAFLD report higher rates of anxiety symptoms compared to the general population, though it remains unclear whether this represents a direct pathophysiological link or reflects the psychological burden of chronic disease management.
It is important to note that there is no official link establishing anxiety as a direct cause of fatty liver disease, nor does fatty liver disease directly cause anxiety through a singular biological pathway. Rather, these conditions appear to share common risk factors and may influence one another through behavioural, metabolic, and inflammatory pathways. Understanding this relationship enables healthcare professionals to adopt a holistic approach to patient care, addressing both hepatic and psychological wellbeing concurrently.
How Fatty Liver Disease Can Affect Mental Health and Anxiety
Receiving a diagnosis of fatty liver disease can significantly impact psychological wellbeing, with many patients experiencing increased anxiety about their health prognosis. The asymptomatic nature of early-stage NAFLD means individuals often feel well despite abnormal liver function tests or imaging findings, creating cognitive dissonance that may fuel health-related anxiety. Concerns about potential progression to non-alcoholic steatohepatitis (NASH), cirrhosis, or hepatocellular carcinoma can be particularly distressing.
The metabolic disturbances associated with NAFLD may also be linked to mental health through biological mechanisms, though the evidence is still emerging. Insulin resistance, systemic inflammation, and dysregulation of the gut-liver axis have all been implicated in mood disorders. Elevated inflammatory cytokines such as interleukin-6 and tumour necrosis factor-alpha, commonly observed in NAFLD, may affect neurotransmitter metabolism and hypothalamic-pituitary-adrenal axis function, potentially contributing to anxiety symptoms. These associations require further research to establish causality.
Fatigue represents one of the most commonly reported symptoms in NAFLD patients and can affect a substantial proportion of individuals with the condition. Persistent tiredness can impair daily functioning, reduce quality of life, and exacerbate feelings of anxiety or low mood. Fatigue in NAFLD is multifactorial, and it is important to assess for other common reversible causes such as anaemia, thyroid dysfunction, obstructive sleep apnoea, or medication side effects. The relationship between hepatic inflammation, metabolic dysfunction, and fatigue remains an active area of research.
Patients with NAFLD may also experience anxiety related to the substantial lifestyle modifications required for disease management. Dietary restrictions, weight loss targets, and increased physical activity demands can feel overwhelming, particularly when combined with other health conditions or life stressors. The chronic nature of NAFLD requires long-term commitment to behavioural change, which can be psychologically taxing and may contribute to feelings of anxiety, frustration, or helplessness. Healthcare professionals should remain alert to these psychological dimensions when supporting patients with fatty liver disease.
Managing Anxiety When You Have Fatty Liver Disease
Effective management of anxiety in the context of fatty liver disease requires an integrated approach addressing both psychological and physical health. Cognitive behavioural therapy (CBT) represents a first-line psychological intervention for anxiety disorders as recommended by NICE (CG113) and has demonstrated efficacy in helping patients develop coping strategies, challenge unhelpful thought patterns, and manage health-related worries. Access to psychological therapies is available through NHS Talking Therapies services, which can be self-referred in most areas of England.
Mindfulness-based interventions and relaxation techniques, including progressive muscle relaxation, diaphragmatic breathing exercises, and guided meditation, can help reduce physiological arousal associated with anxiety. These approaches may be particularly beneficial for individuals experiencing health anxiety related to their liver diagnosis. The NHS Apps Library provides access to several evidence-based apps and online resources offering structured mindfulness programmes suitable for self-directed practice.
For some individuals, pharmacological management of anxiety may be appropriate. NICE guidance (CG113) recommends psychological therapies as first-line treatment; if medication is needed, sertraline is the first choice for generalised anxiety disorder on cost-effectiveness grounds, though it is used off-label for this indication. Licensed alternatives for GAD include escitalopram and paroxetine, or SNRIs such as duloxetine or venlafaxine. The choice should be individualised based on patient factors, comorbidities, and prescriber judgement in line with the BNF and local formulary.
Important cautions apply in liver disease. SSRIs are hepatically metabolised and require careful consideration in hepatic impairment. According to the Summary of Product Characteristics (SmPC), citalopram is limited to a maximum dose of 20 mg daily in hepatic impairment due to QT prolongation risk, and sertraline is not recommended in severe hepatic impairment. A 'start low, go slow' approach is advised, with regular monitoring of liver function tests and clinical status. Benzodiazepines should be avoided or used only for very short-term management due to dependence risks and the risk of precipitating hepatic encephalopathy in liver disease. If a benzodiazepine is necessary, agents with simpler metabolism such as lorazepam, oxazepam, or temazepam are preferred, and specialist advice should be sought in advanced liver disease.
If you experience side effects from any medication, report them via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk or via the Yellow Card app).
Establishing a supportive relationship with healthcare professionals is crucial. Regular monitoring appointments provide opportunities to discuss concerns, review progress, and adjust management plans. Many patients find reassurance in understanding that early-stage NAFLD is often reversible with lifestyle modification, and that disease progression can be prevented through appropriate management. Patient education about the condition, realistic goal-setting, and celebrating small achievements can help reduce anxiety and improve adherence to treatment recommendations. Support groups, either in-person or online, may also provide valuable peer support and reduce feelings of isolation.
Lifestyle Changes to Support Both Liver Health and Mental Wellbeing
Adopting lifestyle modifications that simultaneously benefit liver health and mental wellbeing represents an efficient and holistic approach to managing both conditions. Regular physical activity stands as one of the most effective interventions for both NAFLD and anxiety. The UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity aerobic activity weekly, plus strengthening activities on at least two days per week. Physical activity has been shown to reduce hepatic steatosis, improve insulin sensitivity, and significantly decrease anxiety symptoms through endorphin release and stress reduction. Activities such as brisk walking, swimming, or cycling can be gradually incorporated into daily routines.
Dietary modification plays a central role in NAFLD management whilst also influencing mental health. A Mediterranean-style diet rich in vegetables, fruits, whole grains, legumes, nuts, and olive oil, with moderate fish consumption, has demonstrated benefits for liver health and is associated with reduced depression and anxiety risk. Reducing intake of refined carbohydrates, saturated fats, and processed foods helps address both hepatic steatosis and blood glucose fluctuations that may affect mood stability. Limiting caffeine intake, particularly in the afternoon and evening, can improve sleep quality and reduce anxiety symptoms, though it is worth noting that moderate coffee consumption has been associated with favourable liver outcomes in some studies, so advice should be individualised.
Sleep hygiene represents another crucial intersection between liver and mental health. Poor sleep quality is associated with both NAFLD progression and increased anxiety. Establishing consistent sleep-wake times, creating a relaxing bedtime routine, limiting screen exposure before sleep, and ensuring a comfortable sleep environment can benefit both conditions. Alcohol should be minimised or avoided entirely, as it directly damages the liver and can worsen anxiety, particularly during withdrawal periods. If you need support with alcohol use, NHS services including local drug and alcohol teams can provide confidential help.
Weight loss of 7–10% of body weight has been shown to improve or resolve NAFLD in many patients, with evidence of histological improvements in steatosis, inflammation, and fibrosis, whilst also reducing anxiety symptoms through improved self-esteem, physical capability, and metabolic health. However, weight loss goals should be realistic and gradual (0.5–1 kg per week) to ensure sustainability and prevent psychological distress. Working with a dietitian can provide personalised nutritional guidance that addresses both liver health and psychological wellbeing, ensuring dietary changes feel manageable rather than overwhelming.
When to Seek Medical Help for Anxiety and Fatty Liver Concerns
Recognising when professional medical input is required represents an important aspect of managing both anxiety and fatty liver disease effectively. You should contact your GP if anxiety is affecting your daily life, causing significant distress, or not improving with self-help measures. Physical symptoms such as persistent palpitations, chest tightness, difficulty breathing, or panic attacks warrant assessment to exclude other medical conditions and determine appropriate treatment pathways.
If you are in crisis or experiencing thoughts of self-harm, call 999 or go to your nearest A&E department. For urgent mental health support, contact NHS 111 or your local crisis team. The Samaritans are available 24/7 on 116 123 for confidential emotional support. If you experience severe chest pain or sudden shortness of breath, seek emergency medical attention immediately.
Regarding liver health, certain symptoms require prompt medical attention. Whilst early NAFLD is typically asymptomatic, signs of progressive liver disease include persistent fatigue unrelieved by rest, unexplained weight loss, jaundice (yellowing of skin or eyes), abdominal swelling, easy bruising or bleeding, confusion, or dark urine with pale stools. Any of these symptoms should prompt urgent GP consultation or, if severe, attendance at an emergency department.
Patients diagnosed with fatty liver disease should attend regular monitoring appointments as recommended by their healthcare team. NICE guidance (NG49) recommends risk stratification using non-invasive fibrosis scores such as the FIB-4 or NAFLD fibrosis score in adults to identify those at low risk of advanced fibrosis. If the score is not low risk or there is clinical concern, an Enhanced Liver Fibrosis (ELF) blood test should be arranged. Individuals with results suggesting advanced fibrosis require referral to specialist hepatology services for further assessment and ongoing surveillance. Transient elastography (FibroScan) may also be used according to local pathways. Blood tests monitoring liver function (ALT, AST, GGT, bilirubin, albumin) and metabolic parameters (HbA1c, lipid profile) help assess disease activity and treatment response. Patients with advanced fibrosis or cirrhosis require specialist surveillance, including six-monthly ultrasound for hepatocellular carcinoma and assessment for varices.
If anxiety is interfering with adherence to liver disease management, this should be discussed with healthcare professionals. Psychological barriers to lifestyle modification are common and addressable through appropriate support. Similarly, if prescribed medications for either condition cause concerning side effects or appear ineffective, medical review should be sought rather than discontinuing treatment independently. Report suspected side effects via the MHRA Yellow Card scheme.
Patients should also seek help if they are using alcohol or other substances to cope with anxiety, as this can significantly worsen liver disease. NHS services including local drug and alcohol teams can provide confidential support for substance use concerns. Remember that seeking help early generally leads to better outcomes for both mental health and liver conditions, and healthcare professionals are well-equipped to provide integrated care addressing both aspects of health.
Frequently Asked Questions
Can anxiety cause fatty liver disease?
Anxiety does not directly cause fatty liver disease, but chronic stress and anxiety may contribute to risk factors such as insulin resistance, poor dietary choices, physical inactivity, and disrupted sleep patterns. These behavioural and metabolic changes can increase the likelihood of developing non-alcoholic fatty liver disease (NAFLD), though the relationship is complex and multifactorial rather than a direct cause-and-effect.
Does having fatty liver make you more anxious?
People with fatty liver disease often report higher rates of anxiety symptoms, though this may reflect the psychological burden of managing a chronic condition rather than a direct biological effect. Concerns about disease progression, lifestyle modification demands, and systemic inflammation associated with NAFLD may all contribute to increased anxiety levels in affected individuals.
What medications are safe for anxiety if I have fatty liver?
SSRIs such as sertraline are first-line pharmacological options for anxiety, but require careful dosing in hepatic impairment using a 'start low, go slow' approach with regular liver function monitoring. Benzodiazepines should be avoided due to dependence risks and the potential to precipitate hepatic encephalopathy in liver disease; if necessary, agents with simpler metabolism like lorazepam or oxazepam are preferred with specialist advice.
How can I manage both anxiety and fatty liver at the same time?
An integrated approach works best, combining psychological therapies such as cognitive behavioural therapy (CBT) with lifestyle modifications that benefit both conditions. Regular physical activity (at least 150 minutes weekly), a Mediterranean-style diet, good sleep hygiene, and gradual weight loss of 7–10% body weight can improve both liver health and anxiety symptoms simultaneously.
What's the difference between fatty liver caused by alcohol and anxiety-related fatty liver?
Non-alcoholic fatty liver disease (NAFLD) is primarily caused by metabolic factors such as obesity, insulin resistance, and type 2 diabetes, not by anxiety itself, though anxiety may influence behaviours that increase NAFLD risk. Alcohol-related fatty liver disease results from excessive alcohol consumption and requires complete alcohol abstinence, whereas NAFLD management focuses on metabolic health, diet, and physical activity regardless of anxiety levels.
When should I see a doctor about anxiety and fatty liver concerns?
Contact your GP if anxiety is affecting daily life, causing significant distress, or not improving with self-help measures, or if you develop symptoms of progressive liver disease such as persistent fatigue, jaundice, abdominal swelling, or unexplained weight loss. If you experience thoughts of self-harm, call 999 or contact the Samaritans on 116 123 for immediate support.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
